Matches in SemOpenAlex for { <https://semopenalex.org/work/W2257952048> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2257952048 endingPage "2005" @default.
- W2257952048 startingPage "2005" @default.
- W2257952048 abstract "2005 Background: Different polymorphisms (P) of the enzymes involved in C metabolism could be responsible of the different efficacy and toxicity in patients treated with C. Carboxylesterase (CES) and Cytidine Deaminase (CDD) are involved in hepatic transformation of C to 5’dFUrd. Thymidilate Synthase (TS) and Dihydropyrimidine Dehydrogenase (DPD) P have been related to 5FU efficacy and toxicity. Our objective was to correlate the efficacy and grade 3–4 toxicity of C with genetic P of CES, CDD, TS and DPD. CES and CDD P have not been previously studied. Methods: Metastatic BC and CRC pts treated with C 1250 mg/m2 PO bid d1–14 every 3 weeks, with evaluable or measurable disease, no dermatological disease and normal hepatic function were prospectively included. PCR and sequencing methods were used to analyze CES exon 3 (5841 G>A, 6046 G>A, 6174 G>A, 6320 G>A); CES UTR (823 C>G, 854 G>C); CDD (575 C>T, 771 C>G, 794 G>A, 942 C>G, 943 insC, 1052 A>C); TS genotype (2R/2R, 2R/3R, 3R/3R) and DPD (IVS14+1 G>A). Fisher’s exact test was used for comparisons. Results: 93 pts (45 BC/48 CRC) previously treated were included, median age 67 yrs (38–90). 31 pts experienced grade 3–4 toxicity: hand-foot syndrome (HFS) 15%, asthenia 6.4%, diarrhea 4.3%, vomiting 3.2%, mucositis 2% and anorexia 2%. Nearly significant correlation was detected between heterozygous (HT) and homozygous (HM) P of CDD gene (943 insC) and greater incidence of HFS than in the wild type (WT) (21.3%, 14.2% and 3.5% respectively) (p=0.055), and HM P of CES exon 3 (6046 G>A) and greater diarrhea rate than in the HT or WT (100%, 0% and 3.4% respectively) (p=0.08). 56 pts were evaluable for response (1 CR/23 PR/14 SD/18 PD). 92% of pts with HT and 100% with HM CES UTR (823 C>G) P obtained clinical benefit (CR+PR+EE) compared with 58% of patients with WT (p=0.04). 60% of pts with 2R/2R variant of TS and 87% with 2R/3R had clinical benefit compared with 47% of 3R/3R form (p=0.01). Conclusions: The occurrence of a single nucleotide P in CES UTR gene and some TS variants are associated with improved efficacy of C and can be useful to select patients for this treatment. The lack of statistical significance for grade 3–4 toxicity may be due to the low number of events. The study is ongoing No significant financial relationships to disclose." @default.
- W2257952048 created "2016-06-24" @default.
- W2257952048 creator A5013558016 @default.
- W2257952048 creator A5023000031 @default.
- W2257952048 creator A5024217460 @default.
- W2257952048 creator A5032621510 @default.
- W2257952048 creator A5036532311 @default.
- W2257952048 creator A5046655410 @default.
- W2257952048 creator A5050828329 @default.
- W2257952048 creator A5077791239 @default.
- W2257952048 creator A5087468615 @default.
- W2257952048 creator A5089439568 @default.
- W2257952048 date "2005-06-01" @default.
- W2257952048 modified "2023-09-26" @default.
- W2257952048 title "Pharmacogenetic study in patients (pts) with metastatic breast (BC) and colorectal cancer (CRC) treated with Capecitabine (C)" @default.
- W2257952048 doi "https://doi.org/10.1200/jco.2005.23.16_suppl.2005" @default.
- W2257952048 hasPublicationYear "2005" @default.
- W2257952048 type Work @default.
- W2257952048 sameAs 2257952048 @default.
- W2257952048 citedByCount "2" @default.
- W2257952048 crossrefType "journal-article" @default.
- W2257952048 hasAuthorship W2257952048A5013558016 @default.
- W2257952048 hasAuthorship W2257952048A5023000031 @default.
- W2257952048 hasAuthorship W2257952048A5024217460 @default.
- W2257952048 hasAuthorship W2257952048A5032621510 @default.
- W2257952048 hasAuthorship W2257952048A5036532311 @default.
- W2257952048 hasAuthorship W2257952048A5046655410 @default.
- W2257952048 hasAuthorship W2257952048A5050828329 @default.
- W2257952048 hasAuthorship W2257952048A5077791239 @default.
- W2257952048 hasAuthorship W2257952048A5087468615 @default.
- W2257952048 hasAuthorship W2257952048A5089439568 @default.
- W2257952048 hasConcept C104317684 @default.
- W2257952048 hasConcept C121608353 @default.
- W2257952048 hasConcept C123321153 @default.
- W2257952048 hasConcept C126322002 @default.
- W2257952048 hasConcept C135763542 @default.
- W2257952048 hasConcept C2777063308 @default.
- W2257952048 hasConcept C2777909004 @default.
- W2257952048 hasConcept C2778050828 @default.
- W2257952048 hasConcept C2778496288 @default.
- W2257952048 hasConcept C2779655350 @default.
- W2257952048 hasConcept C2780456651 @default.
- W2257952048 hasConcept C29730261 @default.
- W2257952048 hasConcept C526805850 @default.
- W2257952048 hasConcept C55493867 @default.
- W2257952048 hasConcept C55775858 @default.
- W2257952048 hasConcept C71924100 @default.
- W2257952048 hasConcept C86803240 @default.
- W2257952048 hasConcept C90924648 @default.
- W2257952048 hasConceptScore W2257952048C104317684 @default.
- W2257952048 hasConceptScore W2257952048C121608353 @default.
- W2257952048 hasConceptScore W2257952048C123321153 @default.
- W2257952048 hasConceptScore W2257952048C126322002 @default.
- W2257952048 hasConceptScore W2257952048C135763542 @default.
- W2257952048 hasConceptScore W2257952048C2777063308 @default.
- W2257952048 hasConceptScore W2257952048C2777909004 @default.
- W2257952048 hasConceptScore W2257952048C2778050828 @default.
- W2257952048 hasConceptScore W2257952048C2778496288 @default.
- W2257952048 hasConceptScore W2257952048C2779655350 @default.
- W2257952048 hasConceptScore W2257952048C2780456651 @default.
- W2257952048 hasConceptScore W2257952048C29730261 @default.
- W2257952048 hasConceptScore W2257952048C526805850 @default.
- W2257952048 hasConceptScore W2257952048C55493867 @default.
- W2257952048 hasConceptScore W2257952048C55775858 @default.
- W2257952048 hasConceptScore W2257952048C71924100 @default.
- W2257952048 hasConceptScore W2257952048C86803240 @default.
- W2257952048 hasConceptScore W2257952048C90924648 @default.
- W2257952048 hasIssue "16_suppl" @default.
- W2257952048 hasLocation W22579520481 @default.
- W2257952048 hasOpenAccess W2257952048 @default.
- W2257952048 hasPrimaryLocation W22579520481 @default.
- W2257952048 hasRelatedWork W1989511857 @default.
- W2257952048 hasRelatedWork W2047969495 @default.
- W2257952048 hasRelatedWork W2055025594 @default.
- W2257952048 hasRelatedWork W2141878889 @default.
- W2257952048 hasRelatedWork W2317376769 @default.
- W2257952048 hasRelatedWork W2412069692 @default.
- W2257952048 hasRelatedWork W2804440574 @default.
- W2257952048 hasRelatedWork W2945826264 @default.
- W2257952048 hasRelatedWork W3045478434 @default.
- W2257952048 hasRelatedWork W66189745 @default.
- W2257952048 hasVolume "23" @default.
- W2257952048 isParatext "false" @default.
- W2257952048 isRetracted "false" @default.
- W2257952048 magId "2257952048" @default.
- W2257952048 workType "article" @default.